CHUGAI PHARMACEUTICAL CO., LTD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,826 JPY | +0.94% |
|
+0.40% | -9.66% |
| May. 23 | Tech stocks lift Japan's Nikkei on boost from Nvidia's robust outlook | RE |
| May. 14 | Japan's Nikkei drifts sideways as more earnings, US CPI awaited | RE |
| Sales 2024 * | 1,089B 6.93B | Sales 2025 * | 1,130B 7.19B | Capitalization | 7,866B 50.05B |
|---|---|---|---|---|---|
| Net income 2024 * | 345B 2.2B | Net income 2025 * | 367B 2.33B | EV / Sales 2024 * | 6.49 x |
| Net cash position 2024 * | 796B 5.06B | Net cash position 2025 * | 1,020B 6.49B | EV / Sales 2025 * | 6.06 x |
| P/E ratio 2024 * |
22.8
x | P/E ratio 2025 * |
21.5
x | Employees | 7,604 |
| Yield 2024 * |
1.77% | Yield 2025 * |
1.86% | Free-Float | 38.08% |
More Fundamentals
* Assessed data
More news
Latest transcript on Chugai Pharmaceutical Co., Ltd
More recommendations
More press releases
| 1 day | +0.90% | ||
| 1 week | +0.35% | ||
| Current month | +0.90% | ||
| 1 month | -3.23% | ||
| 3 months | -23.09% | ||
| 6 months | -9.34% | ||
| Current year | -9.70% |
1 week
4 572.00
4 872.00
1 month
4 572.005 148.00
Current year
4 572.006 697.00
1 year
3 767.006 697.00
3 years
3 191.006 697.00
5 years
2 296.676 697.00
10 years
902.336 697.00
| Managers | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 61 | 87-03-31 |
Junichi Nezu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Hisafumi Okabe
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Masayuki Oku
BRD | Director/Board Member | 79 | 15-02-28 |
Motoo Ueno
BRD | Director/Board Member | 66 | 84-03-31 |
James H. Sabry
BRD | Director/Board Member | 65 | 19-02-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 6.57% | 19 M€ | +11.32% | ||
| 1.87% | 57 M€ | +20.75% | ||
| 1.59% | 4 M€ | +19.76% | ||
| 1.53% | 64,792 M€ | +17.17% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-02 | 4,826 | +0.94% | 442 700 |
| 24-05-31 | 4,781 | +1.90% | 6,295,300 |
| 24-05-30 | 4,692 | +0.17% | 2,310,000 |
| 24-05-29 | 4,684 | -1.68% | 2,045,300 |
| 24-05-28 | 4,764 | -0.89% | 1,180,500 |
Delayed Quote Japan Exchange, June 02, 2024 at 10:18 pm EDT
More quotes
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).
Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
4,781
JPY
Average target price
5,975
JPY
Spread / Average Target
+24.97%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -9.70% | 50.03B | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| +9.78% | 210B | |
| -5.52% | 206B | |
| +6.17% | 164B |
- Stock Market
- Equities
- 4519 Stock
